MedPath

Validation of two stable isotopic labels for determination of albumin synthesis rate

Completed
Conditions
liver function / liver failure
Metabolic and Endocrine - Other metabolic disorders
Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
Registration Number
ACTRN12614000541606
Lead Sponsor
Jan Wernerman
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
16
Inclusion Criteria

healthy volunteers

Exclusion Criteria

Age < 18 years
Participation in other trial within 2 months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
albumin synthesis rate<br><br>Albumin fractional synthesis rate is assessed by the flooding technique (Ballmer et al Am J Physiol 1990; 259: E797-803). The incorporation of labeled phenylalanine in plasma albumin is assessed by gas chromatography-mass spectrometry after separating albumin from other plasma proteins. The precursor pool is assessed from the ratio of labeled to unlabeled phenylalanine in plasma. [In the morning after start of infusion on each study occation. Volunteers will be studied twice (protocol 1) on day 1 and 3, or thrice on day 1, after 5 hrs and after 7 days (protocol 2).]
Secondary Outcome Measures
NameTimeMethod
Fibrinogen synthesis rate<br><br>Fibrinogen fractional synthesis rate is assessed by the flooding technique (Ballmer et al Am J Physiol 1990; 259: E797-803). The incorporation of labeled phenylalanine in plasma fibrinogen is assessed by gas chromatography-mass spectrometry after separating fibrinogen from other plasma proteins. The precursor pool is assessed from the ratio of labeled to unlabeled phenylalanine in plasma. [In the morning after start of infusion on each study occation. Volunteers will be studied twice (protocol 1) on day 1 and 3, or thrice on day 1, after 5 hrs and after 7 days (protocol 2).]
© Copyright 2025. All Rights Reserved by MedPath